Status:
COMPLETED
Malaria Prevalence Around Maferinyah, Guinea
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Malaria
Eligibility:
All Genders
6+ years
Brief Summary
Background: Many women in Sub-Saharan Africa get malaria while they are pregnant. Plasmodium falciparum is a parasite that can cause malaria. Placental malaria (PM) caused by P. falciparum can cause ...
Detailed Description
Malaria caused by Plasmodium falciparum continues to be a global problem with devastating consequences, in particular for at-risk populations such as pregnant women and young infants. Pregnancy malari...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- For pregnant women, a study participant must satisfy the following criteria to be enrolled in this study:
- Pregnant women greater than or equal to 18 years of age (or emancipated minors) reporting for routine antenatal care at the health center without acute illness
- The study participant understands the study and gives informed consent for participation
- Willingness to share a positive test result for malaria or helminths with the health center in Maf(SqrRoot)(Registered Trademark)rinyah so treatment can be initiated if necessary
- Willingness to allow stored laboratory specimens to be used for future research
- For children, a study participant must satisfy the following criteria to be enrolled in this study:
- Children 6-12 months of age at time of visit presenting for routine care at the health center without acute illness
- The parent or guardian understands the study and gives informed consent for participation of their child
- Willingness of parent/guardian to share a positive test result for malaria or helminths with the health center in Maferinyah so treatment can be initiated if necessary
- Willingness of parent/guardian to allow stored laboratory specimens to be used for future research
- EXCLUSION CRITERIA:
- Conditions that in the judgment of the Principal Investigator or Clinical Investigators could adversely impact the safety of the study participant, including conditions that may impair the ability of the participant or participant s parent/guardian to understand the study. All such exclusions and the reason for exclusion will be documented.
Exclusion
Key Trial Info
Start Date :
July 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 30 2023
Estimated Enrollment :
3392 Patients enrolled
Trial Details
Trial ID
NCT04105855
Start Date
July 13 2020
End Date
October 30 2023
Last Update
November 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maferinyah Rural Health Training and Research Center
Maferinyah, Guinea